Back

ALTERED MOLECULAR PATHWAYS OBSERVED IN NASO-OROPHARYNGEAL SAMPLES OF SARS-CoV-2 PATIENTS

Akgun, E.; Tuzuner, M. B.; Sahin, B.; Kilercik, M.; Kulah, C.; Cakiroglu, H. N.; Serteser, M.; Unsal, I.; Baykal, A. T.

2020-05-18 infectious diseases
10.1101/2020.05.14.20102558
Show abstract

BackgroundCOVID-19 or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appeared throughout the World and currently affected more than 3.6 million people and caused the death of around 252,000 people. The novel strain of the coronavirus disease is transmittable at a devastating rate with a high rate of severe hospitalization even more so for the elderly population. Currently around 50,000 patients are in a seriously critical situation. Although 1.2 million patients recovered from the disease there are still more than 2.1 Million active cases. Naso-oro-pharyngeal swab samples as the first step towards detecting suspected infection of SARS-CoV-2 provides a non-invasive method for PCR testing at a high confidence rate. Furthermore, proteomics analysis of PCR positive and negative nasooropharyngeal samples provides information on the molecular level which highlights disease pathology. MethodSamples from 15 PCR positive cases and 15 PCR negative cases were analyzed with nanoLC-MS/MS to identify the differentially expressed proteins. ResultsProteomic analyses identified 207 proteins across the sample set and 17 of them were statistically significant. Protein-protein interaction analyses emphasized pathways like Neutrophil degranulation, Innate Immune System, Antimicrobial Peptides. ConclusionNeutrophil Elastase (ELANE), Azurocidin (AZU1), Myeloperoxidase (MPO), Myeloblastin (PRTN3), Cathepsin G (CTSG) and Transcobalamine-1 (TCN1) were found to be significantly altered in naso-oropharyngeal samples of SARS-CoV-2 patients. The identified proteins are linked to alteration in the innate immune system specifically via neutrophil degranulation and NETosis.

Matching journals

The top 13 journals account for 50% of the predicted probability mass.

1
PLOS ONE
based on 1737 papers
Top 49%
10.4%
2
Journal of Medical Virology
based on 95 papers
Top 0.8%
7.7%
3
Scientific Reports
based on 701 papers
Top 28%
6.5%
4
Frontiers in Immunology
based on 140 papers
Top 2%
3.9%
5
International Journal of Molecular Sciences
based on 39 papers
Top 0.5%
3.0%
6
Nature Communications
based on 483 papers
Top 20%
3.0%
7
iScience
based on 74 papers
Top 1%
2.9%
8
Life Science Alliance
based on 11 papers
Top 0.1%
2.9%
9
Viruses
based on 79 papers
Top 1%
2.6%
10
eBioMedicine
based on 82 papers
Top 1%
2.4%
11
Frontiers in Cellular and Infection Microbiology
based on 22 papers
Top 1%
2.4%
12
The Journal of Immunology
based on 19 papers
Top 1%
1.6%
13
Frontiers in Medicine
based on 99 papers
Top 11%
1.6%
50% of probability mass above
14
EMBO Molecular Medicine
based on 15 papers
Top 0.7%
1.6%
15
Journal of Infection
based on 64 papers
Top 4%
1.4%
16
Biomedicines
based on 21 papers
Top 2%
1.4%
17
Clinical Infectious Diseases
based on 219 papers
Top 17%
1.2%
18
Journal of Clinical Virology
based on 54 papers
Top 3%
1.2%
19
European Respiratory Journal
based on 44 papers
Top 4%
1.2%
20
mSphere
based on 27 papers
Top 2%
0.8%
21
Frontiers in Microbiology
based on 36 papers
Top 3%
0.8%
22
Journal of Clinical Microbiology
based on 77 papers
Top 4%
0.8%
23
EBioMedicine
based on 21 papers
Top 2%
0.8%
24
International Journal of Infectious Diseases
based on 115 papers
Top 17%
0.8%
25
Journal of Virological Methods
based on 20 papers
Top 2%
0.8%
26
JCI Insight
based on 63 papers
Top 5%
0.8%
27
Pathogens
based on 16 papers
Top 0.4%
0.8%
28
European Journal of Clinical Microbiology & Infectious Diseases
based on 14 papers
Top 1%
0.7%
29
Microorganisms
based on 21 papers
Top 1%
0.7%
30
Clinical Chemistry
based on 14 papers
Top 2%
0.7%